FQ
EGRX

First Quadrant’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

First Quadrant’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-613
Closed -$34K – 694
2019
Q2 		$34K Buy
+613
New +$34K ﹤0.01% 658